NCT03044301View on ClinicalTrials.gov

Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
No Condition
Interventions
COMBINATION_PRODUCT

Intramuscular ZENEO® injection

Sodium Chloride (0.9 %)

COMBINATION_PRODUCT

Subcutaneous high ZENEO® injection

Sodium Chloride (0.9 %)

COMBINATION_PRODUCT

Subcutaneous low ZENEO® injection

Sodium Chloride (0.9 %)

Sponsors

Lead Sponsor

Crossject
All Listed Sponsors
lead

Crossject

INDUSTRY

NCT03044301 - Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®) | Biotech Hunter | Biotech Hunter